* LeMaitre Vascular Inc LMAT.OQ LMAT.O is expected
to show a
rise in quarterly revenue when it reports results
* The Burlington Massachusetts-based company is expected to
report a 21.9% increase in revenue to $47.58 million from
$39.03 million a year ago, according to the mean estimate from 8
analysts, based on Refinitiv data. The company's guidance on
August 1 2023, for the period ended September 30, was for
revenue between 46.50 million and 48.90 million.
* Refinitiv's mean analyst estimate for LeMaitre Vascular
Inc is
for earnings of 30 cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," 3
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for LeMaitre
Vascular
Inc is $66.5, above its last closing price of $47.90.
The company's guidance on August 1 2023 for the period ended
September 30 was for Earnings before Interest and Taxes between
7.4 million and 8.9 million.The company's guidance on August 1
2023 for the period ended September 30 was for gross profit
margin of 64.3%.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Jun. 30 2023 0.32 0.32 0.36 Beat 13.8
Mar. 31 2023 0.25 0.25 0.27 Beat 7.4
Dec. 31 2022 0.26 0.26 0.25 Missed -3.3
Sep. 30 2022 0.27 0.28 0.25 Missed -9.9
Jun. 0.27 0.27 0.16 Missed -39.6
30 2022
Mar. 31 2022 0.28 0.28 0.27 Missed -2.6
Dec. 31 2021 0.31 0.31 0.28 Missed -8.6
Sep. 30 2021 0.33 0.33 0.30 Missed -7.7
This summary was machine generated October 31 at 01:38 GMT. All
figures in US dollars unless otherwise stated